<DOC>
	<DOCNO>NCT02302287</DOCNO>
	<brief_summary>Food intake deep influence gut microbiota composition function , health disease status . In chronic kidney disease ( CKD ) , microbiota dysbiosis status observe . Moreover , many toxic uremic molecule microbial-derived accumulation promotes , turn , disease progression . Investigators ' hypothesis foresees beneficial effect nutritional treatment , able restore gut microbiota balance , low microbial-derived uremic toxin improve clinical condition CKD patient . Mediterranean Diet ( MD ) suppose beneficial effect microbiota composition , low-protein diet supplement ketoacids ( KD ) use CKD patient improvement clinical condition , effect gut microbiota currently unknown . Investigators ' project aim verify effect MD KD : microbiota metabolome composition , microbial-derived uremic toxin level clinical condition cohort CKD patient .</brief_summary>
	<brief_title>Renal Effects Meditarranean Diet Low-protein Diet With Ketoacids Physiological Intestinal Mibrobiota CKD</brief_title>
	<detailed_description>Background : In CKD biochemical milieu gastrointestinal tract ( GI ) alter several mechanism , affect gut microbiota composition function . Beyond exert metabolic function , microbiota influence general healthy status . It digest food mainly saccharolytic proteolytic catabolism , prevalence former healthy status . On contrary , CKD , dysbiosis prevalence latter observe . In set , reduction glomerular filtration rate increase urea level result heavy influx GI . Here urea hydrolyze spontaneously and/or microbial urease , release ammonia , readily convert ammonium hydroxide . The latter raise GI pH , cause mucosa irritation , enterocolitis change microbiota composition . This contribute worsen inflammation disease progression : indeed , microbiota identify primary source several well know yet unidentified volatile organic compound ( VOC ) , include main uremic toxin . Some beneficial effect observe study low-protein diet supplement ketoacids CKD solely explain reduced protein intake . Investigators ' hypothesis ketoacids may direct protective effect renal damage progression , induced modification gut biochemical milieu microbiota composition . Similarly , Mediterranean Diet fiber supply contribute restore gut microbiota balance . Hypothesis : The first hypothesis foresees beneficial effect KD microbiota balance microbial-derived uremic toxin decrease CKD patient , KD-induced urea reduction . The second envisages MD direct effect gut microbiota composition increase protective specie decrease uremic toxin production . The study evaluate effect three different dietary regimen , compose follow : FD contain 1 g/bw/day protein , plant protein 15-20 g/day ; - MD contain 0.7-0.8 g/bw/day protein , plant protein 40-50 g/day ; - KD contain 0.3-0.5 g/bw/day protein , animal protein zero g/day , plant protein 30-40 g/day , plus ketoacids 0.05 g/bw/day . Specific aim : 1 . To evaluate effect Mediterranean diet ( MD ) low-protein diet supplemented ketoacids ( KD ) microbiota composition 2 . To evaluate effect KD MD microbial-derived VOC ( already identify yet unidentified uremic toxin ) level metabolomics 3 . To evaluate effect KD MD renal function parameter , uremia , inflammatory nutritional status Experimental Design Aim 1 : The design study experimental , randomize , cross-over . It carry accord Declaration Helsinki ( IV Adaptation ) submit approval local Ethics Committee ; write consent obtain subject . 60 patient CKD stage 3b-4 ( MDRD formula ) enrol , accord inclusion exclusion criterion ( see ) . Experimental Design Aim 2 : Untarget metabolomic analysis carry fecal urine sample collect time point describe Experimental design aim 1 VOC ( GC-MS/MS ) non-VOC profiling ( LC-MS/MS ) . Sera collect time point also analyze untarget metabolomic non-VOC profiling target metabolomic quantify already know uremic toxin , namely indoxyl sulfate p-cresyl sulfate , potential metabolite biomarkers find untarget experiment . Experimental Design Aim 3 : Additionally , patient undergo medical examination every three month , evaluation : blood pressure nutritional status . Moreover , time point aim 1 ( T0 , T3 , T9 , T12 T18 month begin study ) patient provide blood urine sample , routine experimental analysis .</detailed_description>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Calcium , Dietary</mesh_term>
	<criteria>prevalent patient tertiary nephrology clinic ; patient 18 year ; CKD stage 3b4 ( eGFR 15 45 ml/min/1.73m2 , estimate MDRD formula ) ; clinically prove adherence prescribed therapy ; inform consent sign . change GFR &gt; 30 % within last 3 month ; acute , intercurrent disease previous 3 month ; severe undernutrition indicate : BMI &lt; 20 kg/m2 serum albumin &lt; 3.2 g/dl , BMI &lt; 17.5 kg/m2 whatever albumin value , body weight reduction &gt; 5 % within last month &gt; 10 % within last six month ; pregnancy feeding ; chronic treatment steroid cytotoxic drug ; fast progress glomerulonephritis ; active SLE vasculitis ; gastrointestinal disease ( Crohn disease , Ulcerative colitis , Celiac Sprue , Stypsis ) ; 7 ) infectious disease ; 8 ) cardiac failure stage IIIIV NYHA ; advance liver cirrhosis ; active cancer disease ; severe encephalopathy associate lack spontaneous feeding ; chronic obstructive respiratory disease need oxygen treatment ; 9 ) use antibiotic probiotic 15 day enrolment ; 10 ) psychiatric disease inability ass followup .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>Chronic kidney disease</keyword>
	<keyword>mediterranean diet</keyword>
	<keyword>low-protein diet</keyword>
	<keyword>ketoacids</keyword>
	<keyword>intestinal microbiota</keyword>
</DOC>